Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Revue Medicale Suisse
|
September 26, 2007
[How to reduce reperfusion time in ST elevation myocardial infarction?]
O Grosgurin, J Plojoux, F P Sarasin
European Neurology
|
January 1, 1997
How to prevent stroke recurrence in patients with patent foramen ovale: anticoagulants, antiaggregants, foramen closure, or nothing?
M Nendaz, F P Sarasin, J Bogousslavsky
Archives of Internal Medicine
|
October 12, 2000
Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack
F P Sarasin, J M Gaspoz, H Bounameaux
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
July 1, 1996
Optimal duration of oral anticoagulant therapy following deep vein thrombosis of lower limbs
H Bounameaux, P de Moerloose, F P Sarasin
Revue Medicale Suisse
|
September 4, 2012
[Comprehensive geriatric assessment in the emergency department: some usefull screening tools]
C E Graf, T Chevalley, F P Sarasin
Hepatology (Baltimore, Md.)
|
August 8, 1998
Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective
F P Sarasin, E Giostra, G Mentha, et al.
Hepatology (Baltimore, Md.)
|
March 25, 2000
Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis
P E Majno, F P Sarasin, G Mentha, et al.
Pharmacoeconomics
|
March 31, 2001
Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland
J V Chancellor, E Hunsche, E de Cruz, et al.
American Heart Journal
|
March 20, 1998
Preventing stroke recurrence in patients with patent foramen ovale: antithrombotic therapy, foramen closure, or therapeutic abstention? A decision analytic perspective
M R Nendaz, F P Sarasin, A F Junod, et al.
Archives of Internal Medicine
|
July 11, 2000
Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis
D G Wahl, H Bounameaux, P de Moerloose, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Revue Medicale Suisse
|
September 26, 2007
[How to reduce reperfusion time in ST elevation myocardial infarction?]
O Grosgurin, J Plojoux, F P Sarasin
European Neurology
|
January 1, 1997
How to prevent stroke recurrence in patients with patent foramen ovale: anticoagulants, antiaggregants, foramen closure, or nothing?
M Nendaz, F P Sarasin, J Bogousslavsky
Archives of Internal Medicine
|
October 12, 2000
Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack
F P Sarasin, J M Gaspoz, H Bounameaux
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
July 1, 1996
Optimal duration of oral anticoagulant therapy following deep vein thrombosis of lower limbs
H Bounameaux, P de Moerloose, F P Sarasin
Revue Medicale Suisse
|
September 4, 2012
[Comprehensive geriatric assessment in the emergency department: some usefull screening tools]
C E Graf, T Chevalley, F P Sarasin
Hepatology (Baltimore, Md.)
|
August 8, 1998
Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective
F P Sarasin, E Giostra, G Mentha, et al.
Hepatology (Baltimore, Md.)
|
March 25, 2000
Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis
P E Majno, F P Sarasin, G Mentha, et al.
Pharmacoeconomics
|
March 31, 2001
Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland
J V Chancellor, E Hunsche, E de Cruz, et al.
American Heart Journal
|
March 20, 1998
Preventing stroke recurrence in patients with patent foramen ovale: antithrombotic therapy, foramen closure, or therapeutic abstention? A decision analytic perspective
M R Nendaz, F P Sarasin, A F Junod, et al.
Archives of Internal Medicine
|
July 11, 2000
Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis
D G Wahl, H Bounameaux, P de Moerloose, et al.
Page
of 5